Recently, researchers have linked both pericellular plasminogen activation and cell surface alpha-enolase to migration and invasion in lung and pancreatic cancer, and these studies have proposed targeting cancer cells with specific anti-alpha-enolase antibodies as a promising approach to suppress tumour metastasis5, 6. The gene discussed is ENO1; the disease is pancreatic neoplasm.